ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death

Author:

Casolo Giancarlo1,Gulizia Michele Massimo2,Aschieri Daniela3,Chinaglia Alessandra4,Corda Marco5,Nassiacos Daniele6,Caico Salvatore Ivan7,Chimenti Cristina8,Giaccardi Marzia9,Gotti Enrico10,Maffé Stefano11,Magnano Roberta12,Solarino Gianluca1,Gabrielli Domenico1314,Oliva Fabrizio15,Colivicchi Furio16

Affiliation:

1. U.O.C. Cardiology, Versilia Hospital , Lido di Camaiore, Lucca 55043

2. U.O.C. Cardiology, Garibaldi-Nesima Hospital, Azienda di Rilievo Nazionale e Alta Specializzazione ‘Garibaldi’ , Catania

3. U.O.C. Cardiology, Guglielmo da Saliceto Hospital , Piacenza

4. S.C. Cardiology, San Luigi Gonzaga Hospital , Orbassano, Torino

5. S.C. Cardiology-UTIC, ARNAS ‘G. Brotzu’ , Cagliari

6. U.O.C Cardiology-UTIC, P.O. Saronno, ASST Valle Olona , Saronno, Varese

7. U.O. Cardiology, Gallarate Hospital, ASST Valle Olona , Gallarate, Varese

8. Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Azienda Ospedaliera Universitaria Policlinico Umberto I , Rome

9. U.O. Cardiology, Santa Maria Annunziata Hospital , Bagno a Ripoli, Florence

10. Department of Nephrological, Cardiac and Vascular Diseases, University of Modena and Reggio Emilia, Baggiovara Civil Hospital , Modena

11. U.O. Cardiology, SS Trinità Hospital, ASL NO , Borgomanero, Novara

12. U.O.C. Cardiology-UTIC, Santo Spirito Hospital , Pescara

13. U.O.C. Cardiology, Department of Cardio-Thoraco-Vascular, Azienda Ospedaliera San Camillo Forlanini , Rome

14. Fondazione per il Tuo cuore—Heart Care Foundation , Florence

15. Cardiology 1-Emodinamics, Cardiothoracovascular Department ‘A. De Gasperis’, ASST Grande Ospedale Metropolitano Niguarda , Milan

16. U.O.C. Clinical and Rehabilitation Cardiology, Presidio Ospedaliero San Filippo Neri—ASL Roma 1 , Rome

Abstract

Abstract Extended risk stratification and optimal management of patients with a permanently increased risk of sudden cardiac death (SCD) are becoming increasingly important. There are several clinical conditions where the risk of arrhythmic death is present albeit only transient. As an example, patients with depressed left ventricular function have a high risk of SCD that may be only transient if there will be a significant recovery of function. It is important to protect the patients while receiving and titrating to the optimal dose the recommended drugs that may lead to an improved left ventricular function. In several other conditions, a transient risk of SCD can be observed even if the left ventricular function is not compromised. Examples are patients with acute myocarditis, during the diagnostic work-up of some arrhythmic conditions or after extraction of infected catheters while eradicating the associated infection. In all these conditions, it is important to offer a protection to these patients. The wearable cardioverter defibrillator (WCD) is of particular importance as a temporary non-invasive technology for both arrhythmia monitoring and therapy in patients with increased risk of SCD. Previous studies have shown the WCD to be an effective and safe therapy for the prevention of SCD caused by ventricular tachycardia/fibrillation. The aim of this ANMCO position paper is to provide a recommendation for clinical utilization of the WCD in Italy, based upon current data and international guidelines. In this document, we will review the WCD functionality, indications, clinical evidence, and guideline recommendations. Finally, a recommendation for the utilization of the WCD in routine clinical practice will be presented, in order to provide physicians with a practical guidance for SCD risk stratification in patients who may benefit from this device.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3